stoxline Quote Chart Rank Option Currency Glossary
  
Medifast, Inc. (MED)
16.21  0.18 (1.12%)    02-14 16:00
Open: 16.3
High: 16.6634
Volume: 235,933
  
Pre. Close: 16.03
Low: 16.12
Market Cap: 177(M)
Technical analysis
2025-02-14 4:49:42 PM
Short term     
Mid term     
Targets 6-month :  19.46 1-year :  22.73
Resists First :  16.66 Second :  19.46
Pivot price 15.61
Supports First :  15.48 Second :  14.76
MAs MA(5) :  15.51 MA(20) :  15.6
MA(100) :  17.74 MA(250) :  22.79
MACD MACD :  -0.3 Signal :  -0.5
%K %D K(14,3) :  54.8 D(3) :  34.9
RSI RSI(14): 53.9
52-week High :  52.22 Low :  14.76
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ MED ] has closed below upper band by 13.6%. Bollinger Bands are 40% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 13 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 16.68 - 16.74 16.74 - 16.82
Low: 15.95 - 16.02 16.02 - 16.09
Close: 16.08 - 16.19 16.19 - 16.32
Company Description

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.

Headline News

Sun, 16 Feb 2025
What Is Medifast, Inc.'s (NYSE:MED) Share Price Doing? - Yahoo Finance

Fri, 14 Feb 2025
Medifast, Inc. (MED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

Tue, 04 Feb 2025
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Business Wire

Tue, 04 Feb 2025
Medifast Earnings Alert: Key Financial Results Coming February 18 - What's at Stake for OPTAVIA - StockTitan

Sat, 25 Jan 2025
JPMorgan Chase & Co. Increases Position in Medifast, Inc. (NYSE:MED) - MarketBeat

Tue, 05 Nov 2024
Medifast, Inc. (NYSE:MED) Q3 2024 Earnings Call Transcript - Insider Monkey

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Consumer Cyclical
Industry:
Personal Products & Services
Shares Out 11 (M)
Shares Float 9 (M)
Held by Insiders 2.5 (%)
Held by Institutions 85.9 (%)
Shares Short 1,400 (K)
Shares Short P.Month 1,410 (K)
Stock Financials
EPS 0.67
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 19.46
Profit Margin 1 %
Operating Margin 1.5 %
Return on Assets (ttm) 4.7 %
Return on Equity (ttm) 3.6 %
Qtrly Rev. Growth -40.6 %
Gross Profit (p.s.) 45.5
Sales Per Share 61.65
EBITDA (p.s.) 2.47
Qtrly Earnings Growth -95.4 %
Operating Cash Flow 40 (M)
Levered Free Cash Flow -7 (M)
Stock Valuations
PE Ratio 24.19
PEG Ratio 0
Price to Book value 0.83
Price to Sales 0.26
Price to Cash Flow 4.43
Stock Dividends
Dividend 1.64
Forward Dividend 0
Dividend Yield 10.1%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android